Diabetes can induce renal MCP-1 production, and serum and urinary MCP1 levels are elevated in early DN, which can be used as markers and possible mediators of early DN, as well as to evaluate renal inflammation in diabetic patients (269, 270). Here, CCL2 is linked to diabetes mellitus.